DB Horton

First name:
DB
Last name:
Horton
Meyer, A. C., Horton, D. B., Neugebauer, N. M., Wooters, T. E., Dwoskin, L. P., & Bardo, M. T. (2011). Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration. Neuropharmacology, 61(4), 849-56. https://doi.org/10.1016/j.neuropharm.2011.05.033
View
Horton, D. B., Siripurapu, K. B., Norrholm, S. D., Culver, J. P., Hojahmat, M., Beckmann, J. S., et al. (2011). meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release. The Journal Of Pharmacology And Experimental Therapeutics, 336(3), 940-51. https://doi.org/10.1124/jpet.110.175117
View
Beckmann, J. S., Siripurapu, K. B., Horton, D. B., Denehy, E. D., Vartak, A., Crooks, P. A., et al. (2010). The novel pyrrolidine nor-lobelane analog UKCP-110 cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats. The Journal Of Pharmacology And Experimental Therapeutics, 335(3), 841-51. https://doi.org/10.1124/jpet.110.172742
View
Beckmann, J. S., Meyer, A. C., Pivavarchyk, M., Horton, D. B., Zheng, G., Smith, A. M., et al. (2015). r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement. Neurochemical Research, 40(10), 2121-30. https://doi.org/10.1007/s11064-015-1680-4
View